Kyowa Kirin Pharmaceuticals Development Limited is a ltd company established in 1996, focused on the research, development, and commercialization of innovative prescription medicines. Based in London, UK, Kyowa Kirin operates under Reg: 03297935. The company’s primary business revolves around addressing unmet medical needs through the creation of novel therapies. Kyowa Kirin specializes in developing and marketing prescription medicines across a diverse range of therapeutic areas. Their core strategy centers on improving patient lives through the advancement of pharmaceutical science. The company’s international presence is significant, with a global footprint encompassing multiple countries. Kyowa Kirin’s activities are primarily classified as “research and experimental development on natural sciences and engineering.” The company’s portfolio includes a range of products targeting specific medical conditions. While the precise size of the company is not publicly available, Kyowa Kirin’s focus is on delivering high-quality, innovative medicines. They leverage a global business mobility program, indicating a commitment to international collaboration and expansion. The company’s SIC codes include: - 72190: Other research and experimental development on natural sciences and engineering, and potentially other related codes depending on specific operational activities.

Kyowa Kirin Pharmaceuticals Development Limited is a ltd company established in 1996, focused on the research, development, and commercialization of innovative prescription medicines. Based in London, UK, Kyowa Kirin operates under Reg: 03297935. The company’s primary business revolves around addressing unmet medical needs through the creation of novel therapies. Kyowa Kirin specializes in developing and marketing prescription medicines across a diverse range of therapeutic areas. Their core strategy centers on improving patient lives through the advancement of pharmaceutical science. The company’s international presence is significant, with a global footprint encompassing multiple countries. Kyowa Kirin’s activities are primarily classified as “research and experimental development on natural sciences and engineering.” The company’s portfolio includes a range of products targeting specific medical conditions. While the precise size of the company is not publicly available, Kyowa Kirin’s focus is on delivering high-quality, innovative medicines. They leverage a global business mobility program, indicating a commitment to international collaboration and expansion. The company’s SIC codes include: - 72190: Other research and experimental development on natural sciences and engineering, and potentially other related codes depending on specific operational activities.